427 related articles for article (PubMed ID: 16585130)
1. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
Navarro-Martínez MD; García-Cánovas F; Rodríguez-López JN
J Antimicrob Chemother; 2006 Jun; 57(6):1083-92. PubMed ID: 16585130
[TBL] [Abstract][Full Text] [Related]
2. Antifolates as antimycotics? Connection between the folic acid cycle and the ergosterol biosynthesis pathway in Candida albicans.
Navarro-Martínez MD; Cabezas-Herrera J; Rodríguez-López JN
Int J Antimicrob Agents; 2006 Dec; 28(6):560-7. PubMed ID: 17046206
[TBL] [Abstract][Full Text] [Related]
3. Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate.
Navarro-Perán E; Cabezas-Herrera J; Campo LS; Rodríguez-López JN
Int J Biochem Cell Biol; 2007; 39(12):2215-25. PubMed ID: 17683969
[TBL] [Abstract][Full Text] [Related]
4. The antifolate activity of tea catechins.
Navarro-Perán E; Cabezas-Herrera J; García-Cánovas F; Durrant MC; Thorneley RN; Rodríguez-López JN
Cancer Res; 2005 Mar; 65(6):2059-64. PubMed ID: 15781612
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of inhibition of wt-dihydrofolate reductase from E. coli by tea epigallocatechin-gallate.
Spina M; Cuccioloni M; Mozzicafreddo M; Montecchia F; Pucciarelli S; Eleuteri AM; Fioretti E; Angeletti M
Proteins; 2008 Jul; 72(1):240-51. PubMed ID: 18214969
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
Zeng YB; Qian YS; Ma L; Gu HN
Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of tea polyphenol epigallocatechin 3-O-gallate and azole drugs against oral Candida isolates.
Behbehani JM; Irshad M; Shreaz S; Karched M
J Mycol Med; 2019 Jun; 29(2):158-167. PubMed ID: 30797684
[TBL] [Abstract][Full Text] [Related]
8. Synergistic mechanisms of retigeric acid B and azoles against Candida albicans.
Sun LM; Cheng AX; Wu XZ; Zhang HJ; Lou HX
J Appl Microbiol; 2010 Jan; 108(1):341-8. PubMed ID: 20002912
[TBL] [Abstract][Full Text] [Related]
9. Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen
DeJarnette C; Luna-Tapia A; Estredge LR; Palmer GE
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581079
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
11. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans.
Hirasawa M; Takada K
J Antimicrob Chemother; 2004 Feb; 53(2):225-9. PubMed ID: 14688042
[TBL] [Abstract][Full Text] [Related]
12. The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility.
Yan L; Li M; Cao Y; Gao P; Cao Y; Wang Y; Jiang Y
J Antimicrob Chemother; 2009 Oct; 64(4):764-73. PubMed ID: 19656781
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of the inhibition of bovine liver dihydrofolate reductase by tea catechins: origin of slow-binding inhibition and pH studies.
Navarro-Perán E; Cabezas-Herrera J; Hiner AN; Sadunishvili T; García-Cánovas F; Rodríguez-López JN
Biochemistry; 2005 May; 44(20):7512-25. PubMed ID: 15895994
[TBL] [Abstract][Full Text] [Related]
14. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.
Onyewu C; Blankenship JR; Del Poeta M; Heitman J
Antimicrob Agents Chemother; 2003 Mar; 47(3):956-64. PubMed ID: 12604527
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.
Sardari S; Mori Y; Kurosawa T; Daneshtalab M
Can J Microbiol; 2003 May; 49(5):344-9. PubMed ID: 12897828
[TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Park BJ; Park JC; Taguchi H; Fukushima K; Hyon SH; Takatori K
Biochem Biophys Res Commun; 2006 Aug; 347(2):401-5. PubMed ID: 16831406
[TBL] [Abstract][Full Text] [Related]
17. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
[TBL] [Abstract][Full Text] [Related]
18. [Azole resistance in Candida albicans].
Perea S
Rev Esp Quimioter; 2000 Sep; 13(3):314-7. PubMed ID: 11086283
[TBL] [Abstract][Full Text] [Related]
19. Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicans-synthesis and biological activity of new 2,4-diaminopyrimidines and 4'-substituted 4-aminodiphenyl sulfones.
Otzen T; Wempe EG; Kunz B; Bartels R; Lehwark-Yvetot G; Hänsel W; Schaper KJ; Seydel JK
J Med Chem; 2004 Jan; 47(1):240-53. PubMed ID: 14695838
[TBL] [Abstract][Full Text] [Related]
20. Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Weig M; Müller FM
Antimicrob Agents Chemother; 2001 Mar; 45(3):966-8. PubMed ID: 11181393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]